Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells $9,203,857.52 in Stock

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the transaction, the chief executive officer now owns 55,134 shares […]

Related Keywords

Canada , Leonards Schleifer , , Catalyst Capital Advisors , Nasdaq , E Fund Management Co , Hedge Funds Weigh In On Regeneron Pharmaceuticals , Cantor Fitzgerald , Regeneron Pharmaceuticals Stock Down , News Ratings For Regeneron Pharmaceuticals Daily , Quarter For Regeneron Pharmaceuticals , Fund Management Co , Royal Bank , Fiera Capital Corp , Regeneron Pharmaceuticals , Capital Investment Advisors , Regeneron Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Stock Down , Capital Corp , Capital Advisors , Fund Management , Regeneron Pharmaceuticals Daily ,